The BLUEDIAMOND IMPLANT is intended to be surgically placed in the maxillary or mandibular molar areas for the purpose providing prosthetic support for dental restorations (Crown, bridges, and overdentures) in partially or fully edentulous individuals. It is used to restore a patient's chewing function in the following situations and with the clinical protocols:

Delaved loading
Immediate loading when good primary stability is achieved and with appropriate occlusal loading.
For the BLUEDIAMOND IMPLANTS with a Thread Length of 5mm,
It is indicated for fixed or removable reconstruction in situations of moderate to severely atrophic jawbone and with adequate bone quality that allows primary stability after implant insertion, where a longer implant cannot be placed due to limited vertical bone height. The recommended healing time before loading is between 10 to 12 weeks.
It is specifically recommended for:
Fixed partial dentures/splinted units (one implant per unit)
Pontic cases in combination with at least one longer implant
Fully edentulous cases with at least one 5 mm Short Implant in combination with 2 longer implants in the anterior region and at least four total implants

Device Description

The BLUEDIAMOND IMPLANT is a dental implant body system made of CP Ti Grade 4 with the surface treated by SLA method. It is intended to be placed in the maxillary or mandibular areas to restore masticatory function.
It has different thread lengths depending on the diameter and length. The Implanted length of the device is the length that is implanted into the bone, including the length from the thread to the shoulder, which is the non-threaded part.
The Gingival (Cuff) area of the device has grooves; the bottom of the grooves indicate the implantable length.
The BLUEDIAMOND IMPLANT is consisted of the following components.
BLUEDIAMOND IMPLANT Cuff Type: The BLUEDIAMOND IMPLANT is a dental implant body system made of CP Ti Grade 4 with the surface treated by SLA method. It is intended to be placed in the maxillary or mandibular areas to restore masticatory function.
Material: CP Ti Grade 4 of ASTM F67
Dimension (mm):

Normal Thread Ø 4.0 x 9.0, 11.0, 13.0, 15.0 (7.0, 9.0); Ø 4.4 x 7.0, 9.0, 11.0, 13.0, 15.0 (5.0, 7.0, 9.0); Ø 4.7 x 7.0, 9.0, 11.0, 13.0, 15.0 (5.0, 7.0, 9.0)
Deep Thread Ø 4.4 x 9.0, 11.0, 13.0, 15.0 (5.0, 7.0, 9.0); Ø 4.8 x 7.0, 9.0, 11.0, 13.0, 15.0 (5.0, 7.0, 9.0); Ø 5.1 x 7.0, 9.0, 11.0, 13.0, 15.0 (5.0, 7.0, 9.0)
Diameter X Total Length (Thread Length):
Normal Thread Ø 4.0: 8.0, 9.0, 10.0, 11.0 (1.0, 2.0); Ø 4.4: 7.0, 8.0, 9.0, 10.0, 11.0 (1.0, 2.0); Ø 4.7: 7.0, 8.0, 9.0, 10.0, 11.0 (1.0, 2.0)
Deep Thread Ø 4.4: 8.0, 9.0, 10.0, 11.0 (1.0, 2.0); Ø 4.8: 7.0, 8.0, 9.0, 10.0, 11.0 (1.0, 2.0); Ø 5.1: 7.0, 8.0, 9.0, 10.0, 11.0 (1.0, 2.0)
Implanted Length (Thread to Shoulder Height): 2.0, 3.0, 4.0
Gingival (Cuff) Height: Not Found

The BLUEDIAMOND IMPLANTs are compatible to abutments of The BLUEDIAMOND IMPLANT System from K182448, K192614, K210161, K203808, K233450.

AI/ML Overview

The provided text is an FDA 510(k) summary for a dental implant device (BLUEDIAMOND IMPLANT). It focuses on demonstrating substantial equivalence to predicate devices, rather than an AI/ML medical device. Therefore, it does NOT contain the specific information required to answer your prompt, such as:

Acceptance Criteria for AI/ML Performance: The document does not describe performance metrics like sensitivity, specificity, AUC, or other measures typically used for AI/ML models. Instead, it focuses on physical and material properties, and mechanical performance (fatigue, pull-out).
Study Proving Device Meets Acceptance Criteria for AI/ML: No AI model training, validation, or testing is described. The "performance test" section refers to fatigue tests and pull-out tests, which are engineering tests for the physical implant, not for an AI algorithm.
Sample Sizes for Test Set (AI/ML): Not applicable, as there's no AI/ML test set.
Data Provenance (AI/ML): Not applicable.
Number of Experts/Qualifications (AI/ML Ground Truth): Not applicable.
Adjudication Method (AI/ML Ground Truth): Not applicable.
MRMC Study (AI/ML): Not applicable.
Standalone Performance (AI/ML): Not applicable.
Type of Ground Truth (AI/ML): Not applicable.
Sample Size for Training Set (AI/ML): Not applicable.
How Ground Truth for Training Set was Established (AI/ML): Not applicable.

The document primarily discusses:

Device Description: Material (CP Ti Grade 4), surface treatment (S.L.A), dimensions, components.
Indications for Use: Placement in maxillary/mandibular molar areas for prosthetic support, delayed and immediate loading protocols, specific recommendations for 5mm thread length implants.
Substantial Equivalence: Comparison of the BLUEDIAMOND IMPLANT to a primary predicate device (ARi ExCon Implant System) and several reference devices based on design, dimensions, material, surface treatment, sterilization, shelf life, and features.
Non-Clinical Testing: Biocompatibility, pyrogen/endotoxin testing, sterilization validation, shelf life, modified surface treatment evaluation, and performance test (fatigue test in accordance with ISO 14801, and pull-out testing), and MR compatibility.

In summary, the provided text describes a physical dental implant device and its regulatory submission to the FDA, not an AI/ML-driven medical device. Therefore, it does not contain the information requested about AI acceptance criteria, performance studies, or ground truth establishment.

Summary

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is in blue and includes the letters "FDA" in a square and the words "U.S. FOOD & DRUG ADMINISTRATION".

December 27, 2024

Megagen Implant Co. Ltd Hyo-Eun Lee 45, Secheon-ro 7-gil, Dasa-eup, Dalseong-gun Daegu, 42921 REPUBLIC OF KOREA

Re: K241972

Trade/Device Name: BLUEDIAMOND IMPLANT Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: Class II Product Code: DZE Dated: November 26, 2024 Received: November 27, 2024

Dear Hyo-Eun Lee:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).

Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-device-advicecomprehensive-regulatory-assistance/unique-device-identification-system-udi-system.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

{2}------------------------------------------------

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Andrew I. Steen -S

Andrew I. Steen Assistant Director DHT1B: Division of Dental and ENT Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

Indications for Use

Submission Number (if known)

K241972

Device Name

BLUEDIAMOND IMPLANT

Indications for Use (Describe)

Delaved loading
Immediate loading when good primary stability is achieved and with appropriate occlusal loading.

For the BLUEDIAMOND IMPLANTS with a Thread Length of 5mm,

It is indicated for fixed or removable reconstruction in situations of moderate to severely atrophic jawbone and with adequate bone quality that allows primary stability after implant insertion, where a longer implant cannot be placed due to limited vertical bone height. The recommended healing time before loading is between 10 to 12 weeks.

It is specifically recommended for:

Fixed partial dentures/splinted units (one implant per unit)
Pontic cases in combination with at least one longer implant
Fully edentulous cases with at least one 5 mm Short Implant in combination with 2 longer implants in the anterior region and at least four total implants

Type of Use (Select one or both. as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{4}------------------------------------------------

510(k) Summary For BLUEDIAMOND IMPLANT (K241972)

This 510(k) Summary is being submitted in accordance with the requirements of 21 CFR Part 807.92.

Date Prepared: December 26, 2024

1. Applicant / Submitter

MegaGen Implant Co., Ltd. 45, Secheon-ro, 7-gil, Dasa-eup, Dalseong-gun, Daegu, Republic of Korea Tel: + 82-53-222-2828

2. Submission Correspondent

Hyo-Eun, Lee MegaGen Implant Co., Ltd. 45, Secheon-ro, 7-gil, Dasa-eup, Dalseong-gun, Daegu, Republic of Korea Tel: +82-53-222-3860 Fax: +82-53-289-3414 Email: ra7@imegagen.com

3. Device

• Trade Name:	BLUEDIAMOND IMPLANT
---------------	---------------------

Endosseous Dental Implant . Common Name:
Implant, Endosseous, Root-Form • Classification Name:
- 872.3640 Classification Regulation:
DZE • Primary Product Code:

4. Predicate Device

• Primary Predicate Device:

K231967 - ARi ExCon Implant System

•Reference Device:

K182448 - BLUEDIAMOND IMPLANT System

K210852 Noris Medical Dental Implants System Cortical
K230618 MegaGen Dental Implant Systems Portfolio MR Conditional
K202942 Straumann® 4 mm Short Implants, Straumann USA, LLC
K213599 SuperLine, Dentium Co., Ltd.

K200586 - Straumann® TLX Implant System, Straumann USA, LLC

K122231 Xpeed AnyRidge Internal Implant System
K192614 Meg-Ball Attachment System, Meg-Loc Abutment, Meg-Magnet Abutment
K210161 AnyOne Onestage Implant System
K203808 Multi-unit Abutment, Multi-unit Angled Abutment
K233450 MegaGen Dental Implant Abutment Scan Healing Abutment; Temporary
Abutment; Temporary Cylinder; Comfort Cap; Healing Cap; Healing Cap Screw; Milling Abutment; EZ Post Abutment; Extra EZ Post Abutment; EZ Post Cylinder; ZrGEN Abutment;

{5}------------------------------------------------

Multi-unit Abutment; Multi-unit Angled Abutment; AXA Abutment (Straight); AXA Abutment (Angled); Abutment Screw; Cylinder Screw; Crown Screw

5. Description

י The BLUEDIAMOND IMPLANT is a dental implant body system made of CP Ti Grade 4 with the surface treated by SLA method. It is intended to be placed in the maxillary or mandibular areas to restore masticatory function.
It has different thread lengths depending on the diameter and length. The Implanted length of the device is the length that is implanted into the bone, including the length from the thread to the shoulder, which is the non-threaded part.

The Gingival (Cuff) area of the device has grooves; the bottom of the grooves indicate the implantable length.

The BLUEDIAMOND IMPLANT is consisted of the following components. '

Device		Content
BLUEDIAMONDND IMPLANT	Cuff Type	Description	The BLUEDIAMOND IMPLANT is a dental implant body system made of CP Ti Grade 4 with the surface treated by SLA method. It is intended to be placed in the maxillary or mandibular areas to restore masticatory function.
		Material	CP Ti Grade 4 of ASTM F67
		Dimension(mm)	- Normal ThreadØ 4.0 x 9.0, 11.0, 13.0, 15.0 (7.0, 9.0)Ø 4.4 x 7.0, 9.0, 11.0, 13.0, 15.0 (5.0, 7.0, 9.0)Ø 4.7 x 7.0, 9.0, 11.0, 13.0, 15.0 (5.0, 7.0, 9.0)- Deep ThreadØ 4.4 x 9.0, 11.0, 13.0, 15.0 (5.0, 7.0, 9.0)Ø 4.8 x 7.0, 9.0, 11.0, 13.0, 15.0 (5.0, 7.0, 9.0)Ø 5.1 x 7.0, 9.0, 11.0, 13.0, 15.0 (5.0, 7.0, 9.0)


			- Normal ThreadØ 4.0: 8.0, 9.0, 10.0, 11.0 (1.0, 2.0)Ø 4.4: 7.0, 8.0, 9.0, 10.0, 11.0 (1.0, 2.0)Ø 4.7: 7.0, 8.0, 9.0, 10.0, 11.0 (1.0, 2.0)- Deep ThreadØ 4.4: 8.0, 9.0, 10.0, 11.0 (1.0, 2.0)Ø 4.8: 7.0, 8.0, 9.0, 10.0, 11.0 (1.0, 2.0)Ø 5.1: 7.0, 8.0, 9.0, 10.0, 11.0 (1.0, 2.0)
			2.0, 3.0, 4.0
		Diameter XTotal Length(Thread Length)	Implanted Length(Thread to Shoulder Height)Gingival (Cuff) Height

י The BLUEDIAMOND IMPLANTs are compatible to abutments of The BLUEDIAMOND IMPLANT System from K182448, K192614, K210161, K203808, K233450.

6. Indication for use

Delayed loading
Immediate loading when good primary stability is achieved and with appropriate occlusal loading.

For the BLUEDIAMOND IMPLANTS with a Thread Length of 5mm,

{6}------------------------------------------------

a longer implant cannot be placed due to limited vertical bone height. The recommended healing time before loading is between 10 to 12 weeks.

It is specifically recommended for:

Fixed partial dentures/splinted units (one implant per unit)
Pontic cases in combination with at least one longer implant
Fully edentulous cases with at least one 5 mm Short Implant in combination with 2 longer implants in the anterior region and at least four total implants

{7}------------------------------------------------

7. Basis for Substantial Equivalence

The BLUEDIAMOND IMPLANT is substantially equivalent to the predicate in terms of indication for use, technical characteristic and function. They are made of the same material and have similar design. The subject of the subject device slightly differ from the predicate device however it is not affecting substantial equivalence.

Based on the technological characteristic comparison tables provided in this submission, we conclude that the subject device is substantially equivalent to the predicate device.

Image /page/7/Figure/3 description: The image shows diagrams of different dental implants with labels and measurements. There are seven different implants shown, each with a different design and labeled with a code such as K231967 or K200586. The implants are labeled with names such as ARi ExCon Implant, BLUEDIAMOND IMPLANT, Noris Medical Dental Implants System -Cortical, Straumann® 4 mm Short Implants, SuperLine -FXSxxxx Series, and Straumann® TLX Implant System. The diagrams include measurements such as L1, L2, L3, and D1, indicating the length and diameter of different parts of the implants.

Dimensions of the implant (Subject and Predicate/references)

	Subject Device	Predicate Device	Reference Device 1	Reference Device 2	Reference Device 3	Reference Device 4	Reference Device 5		For the BLUEDIAMOND IMPLANTSwith a Thread Length of 5mm,It is indicated for fixed or removablereconstruction in situations ofmoderate to severely atrophicjawbone and with adequate bonequality that allows primary stabilityafter implant insertion, where alonger implant cannot be placed dueto limited vertical bone height. Therecommended healing time beforeloading is between 10 to 12 weeks.It is specifically recommended for:- Fixed partial dentures/splinted units(one implant per unit)- Pontic cases in combination with atleast one longer implant- Fully edentulous cases with at leastone 5 mm Short Implant incombination with 2 longer implants inthe anterior region and at least fourtotal implants	achieved and with appropriateocclusal loading.	Lager implats are dedicated for the molarregion.		- Fixed partialdentures/splinted units (oneimplant per unit)- Pontic cases in combinationwith at least one longerimplant- Fully edentulous cases withat least one 4 mm ShortImplant in combination with 2longer implants in the anteriorregion and at least four totalimplants
510k	K241972	K231967	K182448	K210852	K202942	K213599	K200586	Design
DeviceName	BLUEDIAMOND IMPLANT	ARi ExCon Implant	BLUEDIAMOND IMPLANT	Noris Medical Dental ImplantsSystem -Cortical	Straumann® 4 mm ShortImplants	SuperLine -FXSxxxx Series	Straumann® TLX Implant System	WidestThreadDiameter(D1, mm)×TotalLength (L3,mm)	· Normal ThreadØ 4.0 × 9.0, 11.0, 13.0, 15.0Ø 4.4 × 7.0, 9.0, 11.0, 13.0, 15.0Ø 4.7 × 7.0, 9.0, 11.0, 13.0, 15.0· Deep ThreadØ 4.4 × 9.0, 11.0, 13.0, 15.0Ø 4.8 × 7.0, 9.0, 11.0, 13.0, 15.0Ø 5.1 × 7.0, 9.0, 11.0, 13.0, 15.0	· Normal ThreadØ 3.8 × 11.0, 13.0, 15.0Ø 4.3 × 11.0, 13.0, 15.0Ø 4.8 × 11.0, 13.0, 15.0Ø 5.3 × 11.0, 13.0, 15.0· Deep ThreadØ 4.3 × 11.0, 13.0, 15.0Ø 4.8 × 11.0, 13.0, 15.0Ø 5.3 × 11.0, 13.0, 15.0Ø 5.8 × 11.0, 13.0, 15.0	· Normal threadØ3.6 × 7.0, 7.7, 9.2, 10.7, 12.2, 14.2, 17.2Ø4.0 × 7.0, 7.7, 9.2, 10.7, 12.2, 14.2, 17.2Ø4.4 × 7.0, 7.7, 9.2, 10.7, 12.2, 14.2, 17.2Ø4.7 × 7.0, 7.7, 9.2, 10.7, 12.2, 14.2, 17.2Ø5.0 × 7.0, 7.7, 9.2, 10.7, 12.2, 14.2, 17.2· Deep threadØ4.0 × 7.0, 7.7, 9.2, 10.7, 12.2, 14.2, 17.2Ø4.4 × 7.0, 7.7, 9.2, 10.7, 12.2, 14.2, 17.2Ø4.8 × 7.0, 7.7, 9.2, 10.7, 12.2, 14.2, 17.2Ø5.0 × 7.0, 7.7, 9.2, 10.7, 12.2, 14.2, 17.2Ø5.5 × 7.0, 7.7, 9.2, 10.7, 12.2, 14.2, 17.2	Ø4.0 × 11.5, 13.0, 16.0, 18.0, 20.0Ø5.0 × 11.5, 13.0, 16.0Ø6.0 × 11.5, 13.0, 16.0	Ø4.1 × 5.8Ø4.8 x 5.8	Ø3.6 x 7.0Ø4.0 x 7.0Ø4.5 x 7.0Ø5.0 x 7.0Ø5.0 x 7.0Ø5.8 x 7.0	Ø 3.75 × 7.8, 8.8, 11.8, 13.8, 15.8, 17.8, 19.8Ø 4.0 × 7.8, 8.8, 11.8, 13.8, 15.8, 17.8, 19.8Ø 4.5 × 7.8, 8.8, 11.8, 13.8, 15.8, 17.8, 19.8Ø 5.0 × 7.8, 8.8, 11.8, 13.8, 15.8, 17.8, 19.8Ø 5.5 × 7.8, 8.8, 11.8, 13.8Ø 6.5 × 7.8, 8.8, 11.8, 13.8
Manufacturer	MegaGen Implant Co., Ltd.	MegaGen Implant Co., Ltd.	MegaGen Implant Co., Ltd.	Noris Medical LTD	Straumann USA, LLC	Dentium Co., Ltd.	Straumann USA, LLC	ThreadedLength(L1, mm)	· Normal ThreadØ 4.0: 7.0, 9.0Ø 4.4: 5.0, 7.0, 9.0Ø 4.7: 5.0, 7.0, 9.0· Deep ThreadØ 4.4: 7.0, 9.0Ø 4.8: 5.0, 7.0, 9.0Ø 5.1: 5.0, 7.0, 9.0	For all diameters:7.0, 9.0	For all diameters:7.0, 7.7, 9.2, 10.7, 12.2, 14.2, 17.2	Ø 4.0: 6.8, 8.0, 10.0, 11.0, 12.5Ø 5.0: 6.8, 8.0, 10.0Ø 6.0: 6.8, 8.0, 10.0	For all diameters:4.0	For all diameters:5.5	Ø 3.75: 5.0, 7.0, 8.3, 10.3, 12.3, 14.0, 16.0Ø 4.0: 5.0, 7.0, 8.3, 10.3, 12.3, 14.0, 16.0Ø 4.5: 5.0, 7.0, 8.3, 10.3, 12.3, 14.0, 16.0Ø 5.0: 5.0, 7.0, 8.3, 10.3, 12.3, 14.0, 16.0Ø 5.5: 5.0, 7.0, 8.3, 10.3Ø 6.5: 5.0, 7.0, 8.3, 10.3
Indicationfor use	The BLUEDIAMOND IMPLANT isintended to be surgically placed in themaxillary or mandibular molar areasfor the purpose providing prostheticsupport for dental restorations(Crown, bridges, and overdentures) inpartially or fully edentulousindividuals. It is used to restore apatient's chewing function in thefollowing situations and with theclinical protocols:- Delayed loading- Immediate loading when goodprimary stability is achieved and withappropriate occlusal loading.	The ARi ExCon Implant Systemis intended to be surgicallyplaced in the maxillary ormandibular molar areas forthe purpose providingprosthetic support for dentalrestorations (Crown, bridges,and overdentures) in partiallyor fully edentulous individualsIt is used to restore a patient'schewing function in thefollowing situations and withthe clinical protocols:- Delayed loading- Immediate loading whengood primary stability is	The BLUEDIAMOND IMPLANT System isintended to be surgically placed in themaxillary or mandibular molar arches forthe purpose providing prosthetic supportfor dental restorations (Crown, bridges,and overdentures) in partially or fullyedentulous individuals. It is used to restorea patient's chewing function in chewingfunction in the following situations andwith the clinical protocols:- Delayed loading- Immediate loading when good primarystability is achieved and with appropriateocclusal loading. Larger implants arededicated for the molar region.	Noris Medical Dental ImplantsSystem is intended to replacemissing tooth/teeth in either jaw forsupporting prosthetic devices thatmay aid in restoring the patient'schewing function. The procedurecan be accomplished in a one-stageor two-stage surgical operation. Allimplants are appropriate forimmediate loading when goodprimary stability is achieved andwith appropriate occlusal loading.	Straumann® 4 mm ShortImplants are indicated forfixed or removablereconstruction in situations ofmoderate to severely atrophicjawbone and with adequatebone quality that allowsprimary stability after implantinsertion, where a longerimplant cannot be placed dueto limited vertical bone height.The recommended healingtime before loading isbetween 10 to 12 weeks.The 4 mm Short Implants arespecifically recommended for:	SuperLine® implants areindicated for use in surgical andrestorative applications forplacement in the bone of theupper or lower jaw to providesupport for prosthetic devices,such as artificial teeth, in order torestore the patient's chewingfunction. SuperLine® implantsare indicated also for immediateloading when good primarystability is achieved and withappropriate occlusal loading.Single tooth cases on 7 mmlength implants are indicated fordelayed loading.	TLX Dental Implant:Straumann TLX Implants are suitable forendosteal implantation in the upper and lowerjaws and for the functional and esthetic oralrehabilitation of edentulous and partiallyedentulous patients. TLX Implants can be placedwith immediate function on single-tooth andmulti-unit restorations when good primarystability is achieved and with appropriateocclusal loading to restore chewing function.The prosthetic restorations are connected tothe implants through the correspondingabutment components.	ImplantedLength(L2, mm)(Lengthwithin thebone)	· Normal ThreadØ 4.0: 8.0, 9.0, 10.0, 11.0Ø 4.4: 7.0, 8.0, 9.0, 10.0, 11.0Ø 4.7: 7.0, 8.0, 9.0, 10.0, 11.0· Deep ThreadØ 4.4: 8.0, 9.0, 10.0, 11.0Ø 4.8: 7.0, 8.0, 9.0, 10.0, 11.0Ø 5.1: 7.0, 8.0, 9.0, 10.0, 11.0	For all diameters:8.0, 9.0, 10.0, 11.0	For all diameters:7.0, 7.7, 9.2, 10.7, 12.2, 14.2, 17.2	Ø 4.0: 7.5, 9.0, 12.0,14.0, 16.0Ø 5.0: 7.5, 9.0, 12.0Ø 6.0: 7.5, 9.0, 12.0	For all diameters:4.0	For all diameters:5.5	Ø3.75, Ø4.0, Ø4.5, Ø5.0:6.0, 8.0, 10.0, 12.0, 14.0, 16.0, 18.0Ø5.5, Ø6.5: 6.0, 8.0, 10.0, 12.0

{8}------------------------------------------------

{9}------------------------------------------------

Gingival(Cuff)Height(L3-L2,mm)	2.0, 3.0, 4.0	3.0, 4.0	N/A	4.0	1.8*	1.5	1.8*
Thread toShoulderHeight(L2-L1,mm)	1.0, 2.0	1.0, 2.0	N/A	0.7, 1.0, 2.0, 3.0, 3.5	N/A	N/A	1.0, 1.7, 2.0*
Implant toAbutmentConnection	Internal Octa	External Hex	Internal Octa	Internal Hex	Internal	Tapered conical hex	TorcFit(with conical fitting)
Material	CP Ti Grade 4(ASTM F67)	CP Ti Grade 4(ASTM F67)	CP Ti Grade 4(ASTM F67)	Titanium alloy	Roxolid® (Ti-Zr alloy)	All implants: unalloyedtitanium, ASTM F67	Titanium Grade 4
SurfaceTreatment	Sand-blasted, Large grit, Acid-etched (S.L.A)Machined collar	Sand-blasted, Large grit,Acid-etched (S.L.A)Machined collar	Sand-blasted, Large grit, Acid-etched (S.L.A)	RBM (Resorbable BalstingMedia)	SLActive®	All implants: S.L.A., Al2O3blasted and acid etched	Hydrophilic SLActive®
Sterilization	Sterile - irradiation	Sterile - irradiation	Sterile - irradiation	Sterile - irradiation	Sterile - irradiation	Sterile - irradiation	Sterile - irradiation
Shelf Life	5 Years	5 Years	5 Years	5 Years	5 Years	Unknown	5 Years
Type	Tissue level Implant	Tissue level Implant	Bone level Implant	Tissue level Implant	Tissue level Implant	Tissue level Implant	Tissue level Implant
Feature	- Tapered body- 0.8mm thread pitch	- Tapered body- 0.8mm thread pitch	- Submerged implant- Tapered body- cutting edge with self-tapping- 0.8mm thread pitch	- Tapered body- Threaded

Dimensional information not found in the 510(k) Summary for each reference device was taken from the published catalog for that device.

Substantial Equivalence Discussion

1. Similarities

The subject device has the same characteristic for the followings compared to the Predicate device.

Indication for Use, Design, Thread to shoulder Height, Implant to Abutment Connection, Material, Surface, Type and Feature.

2. Differences

The subject device has the different characteristic for the followings compared to the Predicate device.

- Widest Thread Diameter, Total Length

The Widest Thread Diameter and Total Levice is slightly different with predicate device but all the dimensions of subject device lie within rage of predicate device.

- Threaded Length

{10}------------------------------------------------

The Threaded Length of subject device is slightly different with predicate device lie within range of Predicate/Reference devices.

- Implanted Length

The Implanted Length of subject device is slight predicate device. But, all dimensions of subject device lie within range of Predicate/Reference devices.

- Gingival (Cuff) Height

The Gingival (Cuff) Height of subject device is slight predicate device. But, all dimensions of subject device lie within range of Predicatel Reference devices, and the variety of the size can be possible to operate more precise treatment to meet each patient's condition.

3. Discussion

The proposed Cuff type of BLUEDIAMOND INPLANT has common in all the terms in the Widest Thread Diameter, Total Length, Threaded Length, Implanted Length and Gingival (Cuff) Height. But all dimensions of Predicate/Reference devices. Therefore, these differences don't affect the device's fundamental functions, safety and effectiveness

The fatigue test was performed on worst case to confirm the substantial equivalence according to "SO 14801" and "Class II Special Controls Guidance Document: Root-form Endosseous Dental Implants and Endosseous Dental Implant Abutment".

{11}------------------------------------------------

8. Summary of Non-Clinical Testing

The non-clinical testing data which are submitted, referenced, or relied on in this submission support demonstrating substantial equivalence.

Biocompatibility

The biocompatibility evaluation has been performed in accordance with International Standard ISO 10993-1, Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process. The additional biocompatibility testing is not required on the BLUEDIAMOND IMPLANT system since the BLUEDIAMOND IMPLANT system has same material composition, manufacturing process and patient contacting parts as the previously cleared device, XPEED AnyRidge Internal System (K122231), BLUEDIAMOND Implant System (K182448) and AnyRidge Internal Implant System (K110955).

Pyrogen and Endotoxin Test

The subject device will not be labeled as "non-pyrogenic", and the endotoxin testing will be conducted on every batch for the subject device with the testing limit of below 0.5 EU/mL in accordance with the USP 39 <85>.

Sterilization validation and Shelf life

The BLUEDIAMOND IMPLANT is supplied in sterile state. Sterilization validating testing has been performed in accordance with ISO 11137 to verify the sterility assurance level (10°). The tests to validate the shelf life of the device through the proposed shelf life were conducted using the accelerated aging method in accordance to ASTM F1980 and the test results validated 5 years shelf life. The subject device is evaluated with previous device which was evaluated under the previous 510(k) submission, K122231. Also, the following guidance documents were referred to:

Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile.

Modified Surface Treatment

The surface treatment evaluation has been performed in accordance with 'Section 11 of Class II Special Controls Guidance Document: Root-form Endosseous Dental Implants and Endosseous Dental Abutments – Guidance for Industry and FDA Staff". The BLUEDIAMOND IMPLANT has same surface and manufacturing process with the previously our cleared devices of XPEED AnyRidge Internal System (K122231) for the surface treatment of S.L.A.

Performance test

The Fatigue tests have been performed in accordance with "ISO 14801" and "Class II Special Controls Guidance Document: Root-form Endosseous Dental Implants and Endosseous Dental Implant Abutment" to evaluate the performance of the subject devices and the test results met the pre-set criteria.

The surface area analysis and pullout testing were performed on the subject 5 mm threaded length implants, and compared to predicates.

MR Compatibility

The MR compatibility was performed to access the risk of exposing patients who have implantable medical devices according to FDA's guidance "Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment".

An assessment was made to demonstrate that the subject devices do not configure a new worst case and can be represented by the previously conducted studies reviewed for reference devices obtained the status of MR Conditional per K230618. Therefore, the subject devices are MR conditional devices and a patient treated with the subject devices can be safely scanned observing the parameters previously established per reference devices.

{12}------------------------------------------------

9. Conclusion

Based on the information provided in this premarket notification, We, MegaGen Implant Co., Ltd. conclude that the subject device is substantially equivalent to the predicate and reference devices.

Regulation Number and Section

§ 872.3640 Endosseous dental implant.

(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.